Drug Topics

JUNE 2, 2025

The most common barriers to vaccination included finances, logistics, availability of information, and hesitancy or refusal.

Vaccines 482

Vaccines 482

The Checkup by Singlecare

JUNE 2, 2025

Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that is approved by the U.S. Food and Drug Administration (FDA) to treat mental health conditions, including major depressive disorder (MDD), generalized anxiety disorder (GAD), panic attacks caused by panic disorder, and social anxiety disorder (SAD). Also known by the brand name Effexor XR , this antidepressant is also used off-label to treat other medical conditions like neuropathic pain, fibromyalgia, and chronic pain syndro

FDA 75

FDA Labelling 75

PQA

JUNE 6, 2025

Welcome to Five For Friday! Nearly 400 leaders from PQA member organizations attended the 2025 PQA Annual Meeting, May 19-21, to network, engage and gain actionable insights. Attendees heard from more than 60 speakers across the general sessions, breakout sessions, briefing sessions and innovation theaters. During the meeting, PQA presented eight Medicare plan contracts with a PQA Laura Cranston Excellence in Quality or Quality Improvement Award and awarded top posters from the 2025 PQA Annual M

Community Pharmacies 52

Community Pharmacies Communication 52

STAT

JUNE 2, 2025

The Make America Healthy Again commission’s recent report on children’s health has received a lot of attention for its citation errors and focus on ultra-processed foods, smartphones, and stimulant use. But the less-discussed part on “overmedicalization” of American children stood out to us. While the report mentions surgical care only briefly, it identifies two common procedures, adenotonsillectomy and tympanostomy tube (ear tube) placement, as surgeries that “

127

127

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

JUNE 6, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Vaccines 341

Vaccines Immunization Specialty Pharmacies Compounding 341

The Checkup by Singlecare

JUNE 5, 2025

Approximately 11% of American adults have high cholesterol , and approximately 35% of these Americans are taking a statin. These drugs are designed to lower low-density lipoproteins (LDL), reduce triglyceride levels, and slightly raise high-density lipoproteins (HDL). Here’s what statin use looks like in 2025, including how many people are taking them, which statin medications are most commonly prescribed, and how many people experience side effects while taking these drugs.

Mayo Clinic 52

Mayo Clinic Dosage 52

Pharmacy Times

JUNE 2, 2025

The CDC has updated its COVID-19 vaccine guidance for children and pregnant individuals, sparking a debate among health experts and concerns over insurance coverage.

Insurance Coverage 141

Insurance Coverage Vaccines Insurance 141

Drug Topics

JUNE 5, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

Health and Personal Care Stores 247

Health and Personal Care Stores Community Pharmacies Independent Pharmacies Specialty Pharmacies 247

Fierce Healthcare

JUNE 2, 2025

HIV and cancer prevention advocates are among the groups worried over cuts to critical programs at HHS under a new fiscal year 2026 budget request.

77

77

STAT

JUNE 2, 2025

Ice cream, lip gloss, and sparkling water are just a few of the products that can contain neotame — an artificial sweetener that’s 7,000-13,000 times sweeter than sugar. Now researchers have found it’s also in many flavored disposable e-cigarettes, which they warn gives them extra appeal to teens and kids. The study , published Monday in JAMA, found neotame in all 11 of the popular disposable vape brands it tested, including Elf Bar, Breeze, and Mr.

FDA 122

FDA 122

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

JUNE 6, 2025

Juan Ovalles, MD, PhD, discusses how high placebo response rates driven by background therapy complicate lupus drug trials, and outlines evolving strategies in trial design, clinical practice, and pharmacist-led care to ensure investigational biologics are fairly evaluated and appropriately used in systemic lupus erythematosus.

119

119

Drug Topics

JUNE 3, 2025

Social determinants of health have significant impacts on health and quality of life, but little is known about the impact during menopause.

341

341

Fierce Healthcare

JUNE 2, 2025

The Coalition for Health AI (CHAI) has certified its first partnership for AI model validation, after a 16-month effort to get a nationwide network of AI assurance labs up and running.

64

64

PharmTech

JUNE 5, 2025

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

Dosage 52

Dosage 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharmacy Times

JUNE 2, 2025

A study reveals a 14-gene assay guides chemotherapy decisions effectively in patients with early-stage non-small cell lung cancer (NSCLC).

Chemotherapy 65

Chemotherapy 65

Drug Topics

JUNE 3, 2025

A conversation with Erin Albert, MBA, PharmD, JD, DASPL, chief of pharmacy relations, network and privacy, at Cost Plus Drugs.

Independent Pharmacies 466

Independent Pharmacies 466

The Checkup by Singlecare

JUNE 3, 2025

Growing up, there is a strong emphasis on drinking milk to fulfill your vitamin D and calcium needs. But as adults, it’s easy to forget you still need these essential nutrients. While some people eat enough as part of a balanced diet, others develop low calcium levels (calcium deficiency) and may need a prescription supplement like calcitriol , which is sold under the brand name Rocaltrol.

Labelling 97

Labelling FDA 97

STAT

JUNE 2, 2025

CHICAGO — The cancer drug Enhertu stalled the growth of tumors by well over a year in a group of women with a type of metastatic but previously untreated breast cancer — study results reported Monday that the drug’s makers AstraZeneca and Daiichi Sankyo believe could change the way the disease is treated for the first time in a decade.

87

87

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

JUNE 2, 2025

Amid intensified scrutiny of COVID-19 vaccines at HHS, Modernas mRNA-1283 COVID-19 vaccine was granted FDA approval, for patients 65 years and older and patients aged 12 to 64 years with at least 1 or more underlying risk for severe COVID-19.

Vaccines 118

Vaccines FDA 118

Drug Topics

JUNE 6, 2025

News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv

FDA 281

FDA Mayo Clinic Immunization Dosage 281

The Checkup by Singlecare

JUNE 6, 2025

Wegovy (semaglutide) and Mounjaro (tirzepatide) are both prescription drugs that help regulate blood sugar and decrease appetite. However, the Food and Drug Administration (FDA) has approved them for different purposes: Wegovy is approved as a weight loss medication, and Mounjaro is approved as a Type 2 diabetes treatment. Mounjaro’s active ingredient, tirzepatide, is sold as an FDA-approved weight loss drug under the name Zepbound.

Dosage 52

Dosage Adverse Reactions FDA Labelling 52

The Guardian - Pharmaceutical Industry

JUNE 2, 2025

One pharmacist described scarcity of life-saving Creon as worst stock shortage they have dealt with People with pancreatic cancer are eating only one meal a day because of an acute shortage of a drug that helps them digest their food. Patients with cystic fibrosis and pancreatitis are also affected by the widespread scarcity of Creon , a form of pancreatic enzyme replacement therapy (PERT).

76

76

Pharmacy Times

JUNE 2, 2025

National Community Pharmacists Association President Jeff Harrell, PharmD, shares insights from this years event, highlighting its growing impact, the importance of engaging with policymakers, and the urgent issues facing independent pharmacies

Independent Pharmacies 56

Independent Pharmacies 56

Drug Topics

JUNE 3, 2025

Esaxerenone is a nonsteroidal mineralocorticoid receptor blocker that is being studied for its effectiveness for diabetes-associated mineralocorticoid receptor-related hypertension.

341

341

The Checkup by Singlecare

JUNE 5, 2025

Mounjaro (tirzepatide) is a brand name glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Lilly. It’s approved by the Food and Drug Administration to treat Type 2 diabetes and may be prescribed off-label for weight loss. It’s injected under the skin once per week to help control blood sugar levels.

Documentation 52

Documentation Labelling 52

Fierce Pharma

JUNE 6, 2025

PharmaForceIQ’s Stephen Onikoro explains why data, AI and real-time insights are redefining pharma marketing—and what teams must do to stay ahead.

40

40

PhRMA

JUNE 2, 2025

Post-approval R&D is the continued investigation by biopharmaceutical companies, often through lengthy clinical trials, to find new uses and improvements for U.S. Food and Drug Administration (FDA)-approved medicines to better meet patient needs. Recently, there has been growing discussion among IP critics aimed at undermining the importance of post-approval R&D.

FDA 144

FDA 144

Drug Topics

JUNE 3, 2025

In the aftermath of natural disasters, pharmacists play an essential role in the disaster relief team.

315

315

Pharmacy Times

JUNE 3, 2025

The FDA has approved darolutamide for patients with metastatic castration-sensitive prostate cancer after positive results in the ARANOTE clinical trial.

FDA 73

FDA 73

Fierce Pharma

JUNE 6, 2025

How data-driven partnerships and precision engagement are redefining pharma's role in patient care

Patient Care 67

Patient Care 67

Pharmaceutical Technology

JUNE 6, 2025

Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh

Communication 52

Communication Hospitals Packaging Compounding 52

Pharma Marketing Network

JUNE 2, 2025

What if reaching the right patient or HCP at the perfect moment could be done in real timeat scale? Thats no longer a futuristic vision but a reality in 2025. Healthcare digital marketing has rapidly evolved from static display ads to dynamic, data-driven experiences that adapt to users’ behaviors and preferences. For pharma marketers, the stakes have never been higher.

HIPAA 52

HIPAA 52

Pharmacy Times

JUNE 3, 2025

Panelists discuss how ongoing monitoring and individualized treatment adjustments can help mitigate adverse events associated with low-density lipoprotein cholesterol (LDL-C)lowering therapies while maintaining efficacy and explore strategies to navigate insurance barriers and ensure timely access to nonstatin LDL-Clowering medications.

Insurance 65

Insurance 65